Literature DB >> 9213289

Aggression and schizophrenia: efficacy of risperidone.

P F Buckley1, Z Y Ibrahim, B Singer, B Orr, K Donenwirth, P S Brar.   

Abstract

The advent of novel antipsychotic medications has raised treatment expectations for patients with severe mental illness. In this regard, clozapine has been particularly effective in reducing aggressive behavior in patients with schizophrenia. This study compared the efficacy of risperidone and conventional antipsychotic medications in the management of hostile patients. Improvements in the level of aggression were evident over time in both treatment groups, and a similar response between risperidone and typical antipsychotics was observed. Future studies should address the relative role of typical antipsychotics, adjunctive agents, and novel antipsychotic medications in the pharmacological management of persistent aggression in patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9213289

Source DB:  PubMed          Journal:  J Am Acad Psychiatry Law        ISSN: 1093-6793


  7 in total

Review 1.  Seclusion and restraint for people with serious mental illnesses.

Authors:  E Sailas; M Fenton
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 2.  Mentally ill persons in the criminal justice system: some perspectives.

Authors:  H Richard Lamb; Linda E Weinberger; Bruce H Gross
Journal:  Psychiatr Q       Date:  2004

Review 3.  Behavioral and pharmacogenetics of aggressive behavior.

Authors:  Aki Takahashi; Isabel M Quadros; Rosa M M de Almeida; Klaus A Miczek
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 4.  Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression.

Authors:  Aki Takahashi; Isabel M Quadros; Rosa M M de Almeida; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2010-09-03       Impact factor: 4.530

Review 5.  Pharmacological treatment of psychotic agitation.

Authors:  Glenn W Currier; Adam Trenton
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Differences in Total Score of Positive and Negative Syndrome Scale between Bataknese and Javanese Men with Schizophrenia Receiving Risperidone Treatment.

Authors:  Manahap Cerarius F Pardosi; Bahagia Loebis; Muhammad Surya Husada; Nazli M Nasution; Elmeida Effendy; Mustafa M Amin; Vita Camellia
Journal:  Open Access Maced J Med Sci       Date:  2019-07-29

Review 7.  Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).

Authors:  Edoardo G Ostinelli; Mohsin Hussein; Uzair Ahmed; Faiz-Ur Rehman; Krista Miramontes; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2018-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.